Verena Wally

1.4k total citations
48 papers, 969 citations indexed

About

Verena Wally is a scholar working on Cell Biology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Verena Wally has authored 48 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cell Biology, 27 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Verena Wally's work include Skin and Cellular Biology Research (29 papers), RNA regulation and disease (12 papers) and RNA Research and Splicing (9 papers). Verena Wally is often cited by papers focused on Skin and Cellular Biology Research (29 papers), RNA regulation and disease (12 papers) and RNA Research and Splicing (9 papers). Verena Wally collaborates with scholars based in Austria, Germany and Netherlands. Verena Wally's co-authors include Johann Bauer, Eva M. Murauer, Ulrich Koller, Birgit Simon‐Nobbe, Adriano Mari, Stefan Hainzl, P Schneider, M. Breitenbach, Thomas Lettner and Alfred Klausegger and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Verena Wally

46 papers receiving 936 citations

Peers

Verena Wally

PFM

GENET

Stefan Hainzl Austria

Yinghong He Germany

Leila Youssefian United States

Valérie Pendaries France

Francis Palisson Chile

Dimitra Kiritsi Germany

Mari Kishibe Japan

Laura De Rosa Italy

Sergio Capurro Italy

Alain Réano France

Stefan Hainzl Austria

Verena Wally

579 ×1.3

395 ×0.9

120 ×0.6

135 ×1.0

PFM

172 ×1.4

GENET

Citations per year, relative to Verena Wally Verena Wally (= 1×) peers Stefan Hainzl

Countries citing papers authored by Verena Wally

Since Specialization

Citations

This map shows the geographic impact of Verena Wally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Wally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Wally more than expected).

Fields of papers citing papers by Verena Wally

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Wally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Wally. The network helps show where Verena Wally may publish in the future.

Co-authorship network of co-authors of Verena Wally

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Wally. A scholar is included among the top collaborators of Verena Wally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Wally. Verena Wally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ablinger, Michael, et al.. (2025). Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer. Journal of Investigative Dermatology.

Hainzl, Stefan, Johannes Bischof, Thomas Köcher, et al.. (2024). Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa. International Journal of Molecular Sciences. 25(2). 761–761. 5 indexed citations

Verbeeck, Johan, Andrew C. Hooker, Geert Molenberghs, et al.. (2023). Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials. Orphanet Journal of Rare Diseases. 18(1). 391–391. 2 indexed citations

Kottner, Jan, Peter C. van den Akker, Barbara Horváth, et al.. (2023). Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization. British Journal of Dermatology. 189(1). 80–90. 10 indexed citations

Köcher, Thomas, Stefan Hainzl, Johannes Bischof, et al.. (2023). A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa. International Journal of Molecular Sciences. 24(6). 5197–5197. 1 indexed citations

Spuls, Phyllis I., Peter C. van den Akker, Dimitra Kiritsi, et al.. (2023). Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting. British Journal of Dermatology. 190(2). 268–270. 2 indexed citations

Brunner, Susanne M., Caroline J. Rieser, Hannah S. Heil, et al.. (2023). Topical Diacerein Decreases Skin and Splenic CD11c+ Dendritic Cells in Psoriasis. International Journal of Molecular Sciences. 24(5). 4324–4324. 4 indexed citations

Bischof, Johannes, Michael Ablinger, Stefan Hainzl, et al.. (2023). COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents. International Journal of Molecular Sciences. 24(5). 4341–4341. 5 indexed citations

Bischof, Johannes, Thomas Köcher, Stefan Hainzl, et al.. (2022). COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa. Frontiers in Medicine. 9. 976604–976604. 16 indexed citations

10.

Wagner, Roland N., Josefina Piñón Hofbauer, Verena Wally, et al.. (2021). Epigenetic and metabolic regulation of epidermal homeostasis. Experimental Dermatology. 30(8). 1009–1022. 17 indexed citations

11.

Bornert, Olivier, Pauline Nauroy, Johannes Bischof, et al.. (2020). QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study. Journal of Investigative Dermatology. 141(4). 883–893.e6. 40 indexed citations

12.

Wimmer, Monika, Michael Ablinger, Josefina Piñón Hofbauer, et al.. (2020). A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas. Cell Communication and Signaling. 18(1). 61–61. 22 indexed citations

13.

Schwarz, Nicole, Reinhard Windoffer, Thomas M. Magin, et al.. (2017). Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability. Journal of Investigative Dermatology. 138(3). 627–636. 22 indexed citations

14.

Wally, Verena, Florian B. Lagler, Wolfgang Hitzl, et al.. (2013). Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. Orphanet Journal of Rare Diseases. 8(1). 69–69. 40 indexed citations

15.

Wally, Verena, Eva M. Murauer, & Johann Bauer. (2012). Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste. Journal of Investigative Dermatology. 132(8). 1959–1966. 57 indexed citations

16.

Bauer, Johann, Eva M. Murauer, Verena Wally, & Ulrich Koller. (2012). RNA Trans-Splicing for Genodermatoses. Methods in molecular biology. 961. 441–455. 20 indexed citations

17.

Koller, Ulrich, Verena Wally, Lloyd G. Mitchell, et al.. (2011). A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Research. 39(16). e108–e108. 28 indexed citations

18.

Trost, Andrea, Verena Wally, Herbert A. Reitsamer, et al.. (2010). Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration. Mechanisms of Ageing and Development. 131(5). 346–353. 12 indexed citations

19.

Wally, Verena, Alfred Klausegger, Ulrich Koller, et al.. (2007). 5′ Trans-Splicing Repair of the PLEC1 Gene. Journal of Investigative Dermatology. 128(3). 568–574. 55 indexed citations

20.

Rid, Raphaela, Birgit Simon‐Nobbe, Jacqueline M. Langdon, et al.. (2007). Cladosporium herbarum translationally controlled tumor protein (TCTP) is an IgE-binding antigen and is associated with disease severity. Molecular Immunology. 45(2). 406–418. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact